PMH26 Early Impact of COVID-19 Pandemic on Antipsychotic Medication Use Among Patients with Schizophrenia

por Pesa, J., Liberman, J.N., Petrillo, M., Ruetsch, C.
Publicado 2021

Determinants of glycaemic control in a practice setting: the role of weight loss and treatment adherence (The DELTA Study)

por McAdam-Marx, C, Bellows, B K, Unni, S, Mukherjee, J, Wygant, G, Iloeje, U, Liberman, J N, Ye, X, Bloom, F J, Brixner, D I
Publicado 2014